- Home
- FOLD vs CLSK Comparison
FOLD vs CLSK Comparison
Compare FOLD & CLSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOLD
- CLSK
- Stock Information
- Founded
- FOLD 2002
- CLSK 1987
- Country
- FOLD United States
- CLSK United States
- Employees
- FOLD 499
- CLSK N/A
- Industry
- FOLD Biotechnology: Pharmaceutical Preparations
- CLSK Finance: Consumer Services
- Sector
- FOLD Health Care
- CLSK Finance
- Exchange
- FOLD Nasdaq
- CLSK Nasdaq
- Market Cap
- FOLD 2.5B
- CLSK 2.6B
- IPO Year
- FOLD 2007
- CLSK N/A
- Fundamental
- Price
- FOLD $8.42
- CLSK $20.48
- Analyst Decision
- FOLD Strong Buy
- CLSK Strong Buy
- Analyst Count
- FOLD 9
- CLSK 10
- Target Price
- FOLD $26.44
- CLSK $23.25
- AVG Volume (30 Days)
- FOLD 5.3M
- CLSK 40.8M
- Earning Date
- FOLD 11-05-2025
- CLSK 12-01-2025
- Dividend Yield
- FOLD N/A
- CLSK N/A
- EPS Growth
- FOLD N/A
- CLSK N/A
- EPS
- FOLD N/A
- CLSK 0.98
- Revenue
- FOLD $571,160,000.00
- CLSK $631,937,000.00
- Revenue This Year
- FOLD $21.04
- CLSK $110.78
- Revenue Next Year
- FOLD $21.34
- CLSK $43.72
- P/E Ratio
- FOLD N/A
- CLSK $19.89
- Revenue Growth
- FOLD 25.35
- CLSK 84.66
- 52 Week Low
- FOLD $5.51
- CLSK $6.45
- 52 Week High
- FOLD $12.65
- CLSK $23.61
- Technical
- Relative Strength Index (RSI)
- FOLD 57.84
- CLSK 65.07
- Support Level
- FOLD $7.87
- CLSK $18.34
- Resistance Level
- FOLD $8.49
- CLSK $23.61
- Average True Range (ATR)
- FOLD 0.37
- CLSK 1.91
- MACD
- FOLD -0.03
- CLSK 0.12
- Stochastic Oscillator
- FOLD 81.67
- CLSK 66.51
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.
About CLSK CleanSpark Inc.
Cleanspark Inc is a bitcoin mining company. Through CleanSpark, Inc., and the Company's wholly owned subsidiaries, the company mines bitcoin. The company entered the bitcoin mining industry through its acquisition of ATL. Bitcoin mining is the sole reportable segment of the company.